Geno Germano is the founder of Elucida Oncology. Elucida Oncology has raised $75M in total funding. Latest round: Series A. Based in Monmouth Junction, NJ.
Geno Germano is a biopharma veteran and former Pfizer executive who served as the CEO of Elucida Oncology, a clinical-stage biotechnology company focused on targeted cancer therapy. He led Elucida Oncology through a $44 million Series A-1 raise in January 2022 to advance its folate receptor program into Phase I trials. The company, which raised approximately $75 million total, shut down in 2025 due to a lack of funding.
Full founder directory · Investor directory · Company funding database · Fundraising library